November 14, 2007 - Biosensor maker SPO Medical Inc. today said the PulseOx 6000 and PulseOx 6100, two new oximetry devices, will be introduced to the public at the 39th MEDICA World Forum for Medicine in Dusseldorf, Germany Nov. 14-17.
The PulseOx 6000 (finger device) and PulseOx 6100 (hand-held device) are both designed for medical professionals, hospitals and managed care facilities. Based on SPO Medical’s proprietary patented algorithms, both the PulseOx 6000 and PulseOx 6100 use Reflective Pulse Oximetry (RPO) technology for accurate and reliable measurements of blood oxygen saturation and heart rate, utilizing new AutoSpot technology to read in low profusion measurements. The products have been granted CE Mark of approval by the European Union and will be commercially available early in the first quarter of 2008.
For more information: www.spomedical.com, www.medica.de